Myovant Stock Valuation

MYOV -  USA Stock  

USD 20.28  0.22  1.07%

What is the acquisition price tag of Myovant Sciences? Calculating the true value of any business is not as easy as it may seem. While the market cap of a public entity, such as Myovant Sciences, is its stock price multiplied by the total number of shares outstanding, calculating Myovant Sciences' enterprise value requires a different approach. It uses Myovant Sciences' balance sheet items such as long-term debt, the book value of the preferred stock, minority interest, and other important financials.
Myovant Sciences Free Cash Flow is fairly stable at the moment as compared to the past year. Myovant Sciences reported Free Cash Flow of 368.86 Million in 2020. Tangible Asset Value is likely to climb to about 782.3 M in 2021, whereas Enterprise Value is likely to drop slightly above 1.4 B in 2021.
Myovant Sciences secures a last-minute Real Value of $24.27 per share. The latest price of the firm is $20.28. At this time, the firm appears to be undervalued. Our model forecasts the value of Myovant Sciences from analyzing the firm fundamentals such as Operating Margin of (396.32) %, return on equity of 20.67 %, and Shares Outstanding of 91.48 M as well as examining its technical indicators and Probability Of Bankruptcy. In general, we recommend buying undervalued stocks and disposing overvalued stocks since, at some point, asset prices and their ongoing real values will merge together.

Search Valuation 

 
Refresh
Myovant Sciences Valuation Module provides a unique way to ballpark how much the company is worth today. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. We also take into consideration other essential factors such as Myovant Sciences's management style, its c-level domain expertise and tenure, its overall leadership history as well as current capital structure, and future earnings potential.
Undervalued
Today
20.28
27th of July 2021
Share
Please note that Myovant Sciences' price fluctuation is not too volatile at this time. Calculation of the real value of Myovant Sciences is based on 3 months time horizon. Increasing Myovant Sciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Our valuation method for Myovant Sciences is useful when determining the fair value of the Myovant stock, which is usually determined by what a typical buyer is willing to pay for full or partial control of Myovant Sciences. Since Myovant Sciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Myovant Stock. However, Myovant Sciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
24.27
Real Value
26.98
Upside
Estimating the potential upside or downside of Myovant Sciences helps investors to forecast how Myovant stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Myovant Sciences more accurately as focusing exclusively on Myovant Sciences' fundamentals will not take into account other important factors:
Earnings
Estimates (3)
LowProjected EPSHigh
-2.46-1.93-1.33
Details
Hype
Prediction
LowEstimated ValueHigh
17.5620.2722.98
Details
Naive
Forecast
LowNext ValueHigh
16.7519.4522.16
Details
3 Analysts
Consensus
LowTarget PriceHigh
30.0039.0055.00
Details
Traditionally analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. Some money managers use Myovant Sciences' intrinsic value based on its ongoing forecasts of Myovant Sciences' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by look to relative valuation against Myovant Sciences' closest peers. When choosing a valuation method Myovant Sciences, make sure it is appropriate for the firm given its current financial situation and market classification. If more than one is valuation category is appropriate, we suggest using both methods to arrive at a better estimate.

Myovant Valuation Drivers Correlation

Many accounts on the financial statements of Myovant Sciences are highly interrelated and sometimes correlated. Consequently, when conducting Myovant's valuation analysis, one should examine all of the accounts reported to obtain a complete picture of its financial situation. We provide a unique feature to present a conventional correlation table purposely composed against different valuation-related drivers of Myovant
Click cells to compare fundamentals

Myovant Market Cap

Myovant Sciences is regarded third in market capitalization category among related companies. Market capitalization of Biotechnology industry is now estimated at about 13.45 Billion. Myovant Sciences retains roughly 1.86 Billion in market capitalization claiming about 14% of stocks in Biotechnology industry.
Capitalization  Workforce  Revenue  Total debt  Valuation

Myovant Sciences Valuation Ratios as Compared to Competition

Comparative valuation techniques use various fundamental indicators to help in determining Myovant Sciences's current stock value. Our valuation model uses many indicators to compare Myovant Sciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Myovant Sciences competition to find correlations between indicators driving Myovant Sciences's intrinsic value. More Info.
Myovant Sciences is considered to be number one stock in beta category among related companies. It is regarded fourth in price to sales category among related companies fabricating about  10.94  of Price to Sales per Beta. . Price to Sales Ratio is likely to drop to 27.95 in 2021

About Myovant Sciences Valuation

The equity valuation mechanism determines the current worth of Myovant Sciences on a weekly basis. We use both absolute as well as relative valuation methodologies to arrive at the intrinsic value of Myovant Sciences. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Myovant Sciences based exclusively on its fundamental and basic technical indicators. By analyzing Myovant Sciences's financials, quarterly and monthly indicators, and its related drivers such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Myovant Sciences's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Myovant Sciences. We calculate exposure to Myovant Sciences's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Myovant Sciences's related companies.
Last ReportedProjected for 2021
Gross Profit53.1 M52.8 M
Profit Margin(3.87) (4.17) 
Myovant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for womens health and endocrine diseases. Myovant Sciences Ltd. operates as a subsidiary of Sumitovant Biopharma Ltd. Myovant Sciences operates under Biotechnology classification in the United States and is traded on New York Stock Exchange. It employs 407 people.

Myovant Sciences Quarterly Enterprise Value

1.48 BillionShare

Myovant Sciences Valuation Growth Rates

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines. Note, investing in growth stocks can be very risky. If the company such as Myovant Sciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Quick Ratio2.45
Enterprise Value To Ebitda-7.14
Enterprise Value To Revenue28.01

Myovant Sciences Current Valuation Indicators

Valuation refers to the process of determining the present value of Myovant Sciences and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Myovant we look at many different elements of the entity such as Myovant's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Additionally, see Stocks Correlation. Note that the Myovant Sciences information on this page should be used as a complementary analysis to other Myovant Sciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Complementary Tools for Myovant Stock analysis

When running Myovant Sciences price analysis, check to measure Myovant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Myovant Sciences is operating at the current time. Most of Myovant Sciences' value examination focuses on studying past and present price action to predict the probability of Myovant Sciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Myovant Sciences' price. Additionally, you may evaluate how the addition of Myovant Sciences to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Go
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
The market value of Myovant Sciences is measured differently than its book value, which is the value of Myovant that is recorded on the company's balance sheet. Investors also form their own opinion of Myovant Sciences' value that differs from its market value or its book value, called intrinsic value, which is Myovant Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myovant Sciences' market value can be influenced by many factors that don't directly affect Myovant Sciences underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Myovant Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Myovant Sciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myovant Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.